AMOEBA (EPA:ALMIB) | Finanzwire

PRESS RELEASE

published on 05/20/2025 at 19:00, 1 year 5 months ago

Amoéba announces the nomination of Charlotte Franceries, a leading figure in the cosmetics and communications industry, to its Board of Directors
Amoéba announces the proposed appointment of Charlotte Franceries as a member of its Board of Directors, bringing extensive expertise from the cosmetics industry

AMOEBA Board Of Directors Appointment Cosmetics Industry Charlotte Franceries
BRIEF

published on 05/12/2025 at 18:05, 1 year 5 months ago

Amoéba and Koppert in final phase before the launch of AXPERA

Biocontrol Agricultural Innovation Authorizations AXPERA Launch Amoéba Koppert
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 5 months ago

Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.
Amoéba to continue preparing for commercial launch of biocontrol solution AXPERA with Koppert, following successful authorisations. Company aims to meet market expectations for innovative biocontrol solutions

AMOEBA Biocontrol Commercial Launch AXPERA Koppert
BRIEF

published on 05/06/2025 at 08:05, 1 year 6 months ago

Amoéba obtains an exemption in the Netherlands for AXPERA

AMOEBA Biocontrol Authorisation AXPERA The Netherlands
PRESS RELEASE

published on 05/06/2025 at 08:00, 1 year 6 months ago

Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials
Amoéba obtained authorisation for trials of AXPERA in the Netherlands, allowing consumption of treated crops. The Dutch greenhouse market is a strategic showcase for showcasing AXPERA's value in biocontrol fungicide

AMOEBA Biocontrol Netherlands AXPERA Greenhouse Market
BRIEF

published on 04/22/2025 at 18:05, 1 year 6 months ago

Emergency authorization for Amoéba's AXPERA product in France

AMOEBA Biocontrol AXPERA Vine Mildew Emergency Authorization
PRESS RELEASE

published on 04/22/2025 at 18:00, 1 year 6 months ago

New strategic milestone for Amoéba: Axpéra biocontrol product receives emergency market authorisation in France // A proven new solution to help winegrowers combat grapevine downy mildew
Amoéba receives emergency marketing authorization for AXPERA biocontrol product to combat grapevine downy mildew, helping French winegrowers against phytosanitary challenges

AMOEBA Biocontrol AXPERA Emergency Authorization Grapevine Downy Mildew
BRIEF

published on 04/17/2025 at 18:05, 1 year 6 months ago

Amoéba publishes its 2024 Universal Registration Document

AMOEBA AMF Financial Report Corporate Governance Registration Document
PRESS RELEASE

published on 04/17/2025 at 18:00, 1 year 6 months ago

Amoéba announces the publication of its Universal Registration Document 2024
Amoéba announces filing of 2024 Universal Registration Document with French Financial Markets Authority, including financial reports and corporate governance details

AMOEBA French Financial Markets Authority GreenTech Microbiological Solutions 2024 Universal Registration Document
BRIEF

published on 04/14/2025 at 08:50, 1 year 6 months ago

AMOEBA: Initiation of Coverage by KBC Securities and International Expansion

AMOEBA International Biocontrol Cosmetic KBC Securities

Published on 11/06/2026 at 22:15, 12 hours 23 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 21 hours 38 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 22 hours 8 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 22 hours 8 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day ago

Mongolia Tax Audit

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 14 hours 23 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 15 hours 22 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 15 hours 38 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 16 hours 5 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 16 hours 38 minutes ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 16 hours 38 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 16 hours 38 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 16 hours 43 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 17 hours 3 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 23 hours 33 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News